Suppr超能文献

中间蛋白代谢先天性缺陷中饮食摄入、生长与身体成分之间的关系

The Relationship between Dietary Intake, Growth, and Body Composition in Inborn Errors of Intermediary Protein Metabolism.

作者信息

Evans Maureen, Truby Helen, Boneh Avihu

机构信息

Department of Metabolic Medicine, Royal Children's Hospital and Murdoch Children's Research Institute, Melbourne, Australia; Department of Nutrition and Food Services, Royal Children's Hospital, Melbourne, Australia; Department of Nutrition, Dietetics and Food, Monash University, Melbourne, Australia.

Department of Nutrition, Dietetics and Food, Monash University, Melbourne, Australia.

出版信息

J Pediatr. 2017 Sep;188:163-172. doi: 10.1016/j.jpeds.2017.05.048. Epub 2017 Jun 17.

Abstract

OBJECTIVES

To examine relationships between dietary intake, growth and body composition patterns in patients with inborn errors of intermediary protein metabolism and to determine a safe protein:energy ratio (P:E ratio) associated with optimal growth outcomes.

STUDY DESIGN

Retrospective longitudinal data of growth and dietary intake in patients (n = 75) with isovaleric acidemia (IVA; n = 7), methylmalonic acidemia/propionic acidemia (MMA/PA; n = 14), urea cycle defects (UCD; n = 44), classical maple syrup urine disease (MSUD; n = 10) were collected. Prospective longitudinal data of growth, dietary intake, and body composition from 21 patients: IVA (n = 5), MMA/PA (n = 6), UCD (n = 7), and MSUD (n = 3) were collected at clinic visits.

RESULTS

Fifty-two of 75 (66%), 49 of 74 (68%), and 44 of 65 (68%) patients had a z-score of 0 (±1) for lifetime weight, height, and body mass index, respectively. Patients with MMA/PA had the lowest median height and weight z-scores, and MSUD patients had highest median body mass index z-score at all ages. In IVA, MMA/PA, and UCD, total natural protein intake met or exceeded the Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO)/United Nations University (UNU) recommended safe levels. Median percentage fat mass was 17.6% in IVA, 20.7% in MMA/PA, 19.4% in UCD, and 17.8% in MSUD. There was a significant negative correlation between percentage fat mass and total protein intake in IVA, MMA/PA, and UCD (r = -0.737; P = .010). The correlation between the P:E ratio and growth variables in IVA, MMA/PA, and UCD suggest a safe P:E ratio (>1.5 to < 2.9) g protein:100 kcal/day.

CONCLUSION

Growth outcomes in inborn errors of intermediary protein metabolism are not always ideal. Most patients with IVA, MMA/PA, and UCD consume sufficient natural protein to meet FAO/WHO/UNU recommendations. A P:E ratio range of (>1.5 to < 2.9)g protein/100 kcal/day correlates with optimal growth outcomes.

摘要

目的

研究中间蛋白代谢先天性缺陷患者的饮食摄入、生长和身体成分模式之间的关系,并确定与最佳生长结果相关的安全蛋白质:能量比(P:E比)。

研究设计

收集了75例患者(异戊酸血症(IVA;n = 7)、甲基丙二酸血症/丙酸血症(MMA/PA;n = 14)、尿素循环缺陷(UCD;n = 44)、经典枫糖尿症(MSUD;n = 10))的生长和饮食摄入的回顾性纵向数据。在门诊就诊时收集了21例患者(IVA(n = 5)、MMA/PA(n = 6)、UCD(n = 7)、MSUD(n = 3))的生长、饮食摄入和身体成分的前瞻性纵向数据。

结果

75例患者中有52例(66%)、74例患者中有49例(68%)、65例患者中有44例(68%)的终身体重、身高和体重指数的z值分别为0(±1)。MMA/PA患者的身高和体重z值中位数最低,MSUD患者在各年龄段的体重指数z值中位数最高。在IVA、MMA/PA和UCD中,天然蛋白质总摄入量达到或超过了联合国粮食及农业组织(FAO)/世界卫生组织(WHO)/联合国大学(UNU)推荐的安全水平。IVA患者的脂肪量中位数为17.6%,MMA/PA患者为20.7%,UCD患者为19.4%,MSUD患者为17.8%。IVA、MMA/PA和UCD患者的脂肪量百分比与总蛋白质摄入量之间存在显著负相关(r = -0.737;P = 0.010)。IVA、MMA/PA和UCD患者的P:E比与生长变量之间的相关性表明安全的P:E比(>1.5至<2.9)克蛋白质:100千卡/天。

结论

中间蛋白代谢先天性缺陷患者的生长结果并不总是理想的。大多数IVA、MMA/PA和UCD患者摄入的天然蛋白质足以满足FAO/WHO/UNU的建议。P:E比范围为(>1.5至<2.9)克蛋白质/100千卡/天与最佳生长结果相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验